Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

First Page		Document Content
Date: 2014-02-21 12:10:36 Stem cells Transplantation medicine Graft-versus-host disease Hematopoietic stem cell transplantation Cell therapy Center for International Blood and Marrow Transplant Research Donor lymphocyte infusion Stem cell treatments Rituximab Medicine Biology Health		Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients Add to Reading List Source URL: www.mesoblast.com Download Document from Source Website File Size: 260,42 KB Share Document on Facebook

	ASX ANNOUNCEMENT 7 April 2016 Cynata Reports Compelling Results from Pre-clinical Stem Cell Study in Graft-versus-Host Disease (GvHD) DocID: 1t93Q - View Document
	Microsoft Word - ISBT_definitions_final_2011_TRALIcorrectionadopted2013_IHNlogo.doc DocID: 1rsUZ - View Document
	Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer DocID: 1riiF - View Document
	UMBILICAL CORD BLOOD BANKING A guide for parents This guide has been elaborated by the Council of Europe European DocID: 1rf0W - View Document
	Regulatory T cells in Chronic GVHD João Forjaz de Lacerda, MD PhD University of Lisbon DocID: 1r4e5 - View Document